Publication | Closed Access

Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial

VaccinationCervical Cancer ScreeningCancer-associated VirusCervical CancerCervical HealthHuman Papillomavirus VaccinesImmunologyVaccine TrialTherapeutic VaccineInterim ResultsPublic HealthImmunotherapyMedicineRadiation OncologyCervical Cancer Prevention